Tralkoxydim; Notice of Filing a Pesticide Petition to Establish a Tolerance for a Certain Pesticide Chemical in or on Food, 36164-36167 [05-12076]
Download as PDF
36164
Federal Register / Vol. 70, No. 119 / Wednesday, June 22, 2005 / Notices
any more susceptible than adult animals
and the fact that the current RfD
calculated from the NOAEL from the rat
chronic study already incorporates a
300x uncertainty factor, Griffin believes
that an adequate margin of safety is,
therefore, provided by the RfD
established by EPA. There is no
evidence that propazine has endocrinemodulation characteristics as
demonstrated by the lack of endocrine
effects in developmental, subchronic,
and chronic studies. There is no
potential exposure to propazine via
dietary, water, or non-occupational
routes based on the proposed use on
grain sorghum. No additional
uncertainty factor for infants and
children is warranted based on the
completeness and reliability of the data
base, the demonstrated lack of increased
risk to developing organisms, and the
lack of endocrine-modulating effects.
F. International Tolerances
There are no Codex Alimentarius
Commission (CODEX) maximum
residue levels (MRLs) established for
residues of propazine and its chloro
metabolites in or on raw agricultural
commodities.
[FR Doc. 05–12015 Filed 6–21–05; 8:45 am]
BILLING CODE 6560–50–S
ENVIRONMENTAL PROTECTION
AGENCY
[OPP–2005–0140; FRL–7715–6]
Tralkoxydim; Notice of Filing a
Pesticide Petition to Establish a
Tolerance for a Certain Pesticide
Chemical in or on Food
Environmental Protection
Agency (EPA).
ACTION: Notice.
AGENCY:
SUMMARY: This notice announces the
initial filing of a pesticide petition
proposing the establishment of
regulations for residues of a certain
pesticide chemical in or on various food
commodities.
DATES: Comments, identified by docket
identification (ID) number OPP–2005–
0140, must be received on or before July
22, 2005.
ADDRESSES: Comments may be
submitted electronically, by mail, or
through hand delivery/courier. Follow
the detailed instructions as provided in
Unit I. of the SUPPLEMENTARY
INFORMATION.
FOR FURTHER INFORMATION CONTACT: Jim
Tompkins, Registration Division
(7505C), Office of Pesticide Programs,
Environmental Protection Agency, 1200
VerDate jul<14>2003
21:12 Jun 21, 2005
Jkt 205001
Pennsylvania Ave., NW., Washington,
DC 20460–0001; telephone number:
(703) 305–5697; e-mail
address:Tompkins.Jim@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this Action Apply to Me?
You may be potentially affected by
this action if you an agricultural
producer, food manufacturer, or
pesticide manufacturer. Potentially
affected entities may include, but are
not limited to:
• Crop production (NAICS 111)
• Animal production (NAICS 112)
• Food manufacturing (NAICS 311)
• Pesticide manufacturing (NAICS
32532)
This listing is not intended to be
exhaustive, but rather provides a guide
for readers regarding entities likely to be
affected by this action. Other types of
entities not listed in this unit could also
be affected. The North American
Industrial Classification System
(NAICS) codes have been provided to
assist you and others in determining
whether this action might apply to
certain entities. If you have any
questions regarding the applicability of
this action to a particular entity, consult
the person listed under FOR FURTHER
INFORMATION CONTACT.
B. How Can I Get Copies of this
Document and Other Related
Information?
1. Docket. EPA has established an
official public docket for this action
under docket ID number OPP–2005–
0140. The official public docket consists
of the documents specifically referenced
in this action, any public comments
received, and other information related
to this action. Although a part of the
official docket, the public docket does
not include Confidential Business
Information (CBI) or other information
whose disclosure is restricted by statute.
The official public docket is the
collection of materials that is available
for public viewing at the Public
Information and Records Integrity
Branch (PIRIB), Rm. 119, Crystal Mall
#2, 1801S. Bell St., Arlington, VA. This
docket facility is open from 8:30 a.m. to
4 p.m., Monday through Friday,
excluding legal holidays. The docket
telephone number is (703) 305–5805.
2. Electronic access. You may access
this Federal Register document
electronically through the EPA Internet
under the ‘‘Federal Register’’ listings at
https://www.epa.gov/fedrgstr/.
An electronic version of the public
docket is available through EPA’s
electronic public docket and comment
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
system, EPA Dockets. You may use EPA
Dockets at https://www.epa.gov/edocket/
to submit or view public comments,
access the index listing of the contents
of the official public docket, and to
access those documents in the public
docket that are available electronically.
Although not all docket materials may
be available electronically, you may still
access any of the publicly available
docket materials through the docket
facility identified in Unit I.B.1. Once in
the system, select ‘‘search,’’ then key in
the appropriate docket ID number.
Certain types of information will not
be placed in the EPA Dockets.
Information claimed as CBI and other
information whose disclosure is
restricted by statute, which is not
included in the official public docket,
will not be available for public viewing
in EPA’s electronic public docket. EPA’s
policy is that copyrighted material will
not be placed in EPA’s electronic public
docket but will be available only in
printed, paper form in the official public
docket. To the extent feasible, publicly
available docket materials will be made
available in EPA’s electronic public
docket. When a document is selected
from the index list in EPA Dockets, the
system will identify whether the
document is available for viewing in
EPA’s electronic public docket.
Although not all docket materials may
be available electronically, you may still
access any of the publicly available
docket materials through the docket
facility identified in Unit I.B. EPA
intends to work towards providing
electronic access to all of the publicly
available docket materials through
EPA’s electronic public docket.
For public commenters, it is
important to note that EPA’s policy is
that public comments, whether
submitted electronically or in paper,
will be made available for public
viewing in EPA’s electronic public
docket as EPA receives them and
without change, unless the comment
contains copyrighted material, CBI, or
other information whose disclosure is
restricted by statute. When EPA
identifies a comment containing
copyrighted material, EPA will provide
a reference to that material in the
version of the comment that is placed in
EPA’s electronic public docket. The
entire printed comment, including the
copyrighted material, will be available
in the public docket.
Public comments submitted on
computer disks that are mailed or
delivered to the docket will be
transferred to EPA’s electronic public
docket. Public comments that are
mailed or delivered to the docket will be
scanned and placed in EPA’s electronic
E:\FR\FM\22JNN1.SGM
22JNN1
Federal Register / Vol. 70, No. 119 / Wednesday, June 22, 2005 / Notices
public docket. Where practical, physical
objects will be photographed, and the
photograph will be placed in EPA’s
electronic public docket along with a
brief description written by the docket
staff.
C. How and To Whom Do I Submit
Comments?
You may submit comments
electronically, by mail, or through hand
delivery/courier. To ensure proper
receipt by EPA, identify the appropriate
docket ID number in the subject line on
the first page of your comment. Please
ensure that your comments are
submitted within the specified comment
period. Comments received after the
close of the comment period will be
marked ‘‘late.’’ EPA is not required to
consider these late comments. If you
wish to submit CBI or information that
is otherwise protected by statute, please
follow the instructions in Unit I.D. Do
not use EPA Dockets or e-mail to submit
CBI or information protected by statute.
1. Electronically. If you submit an
electronic comment as prescribed in this
unit, EPA recommends that you include
your name, mailing address, and an email address or other contact
information in the body of your
comment. Also include this contact
information on the outside of any disk
or CD ROM you submit, and in any
cover letter accompanying the disk or
CD ROM. This ensures that you can be
identified as the submitter of the
comment and allows EPA to contact you
in case EPA cannot read your comment
due to technical difficulties or needs
further information on the substance of
your comment. EPA’s policy is that EPA
will not edit your comment, and any
identifying or contact information
provided in the body of a comment will
be included as part of the comment that
is placed in the official public docket,
and made available in EPA’s electronic
public docket. If EPA cannot read your
comment due to technical difficulties
and cannot contact you for clarification,
EPA may not be able to consider your
comment.
i. EPA Dockets. Your use of EPA’s
electronic public docket to submit
comments to EPA electronically is
EPA’s preferred method for receiving
comments. Go directly to EPA Dockets
at https://www.epa.gov/edocket/, and
follow the online instructions for
submitting comments. Once in the
system, select ‘‘search,’’ and then key in
docket ID number OPP–2005–0140. The
system is an ‘‘anonymous access’’
system, which means EPA will not
know your identity, e-mail address, or
other contact information unless you
provide it in the body of your comment.
VerDate jul<14>2003
21:12 Jun 21, 2005
Jkt 205001
ii. E-mail. Comments may be sent by
e-mail to opp-docket@epa.gov,
Attention: Docket ID Number OPP–
2005–0140. In contrast to EPA’s
electronic public docket, EPA’s e-mail
system is not an ‘‘anonymous access’’
system. If you send an e-mail comment
directly to the docket without going
through EPA’s electronic public docket,
EPA’s e-mail system automatically
captures your e-mail address. E-mail
addresses that are automatically
captured by EPA’s e-mail system are
included as part of the comment that is
placed in the official public docket, and
made available in EPA’s electronic
public docket.
iii. Disk or CD ROM. You may submit
comments on a disk or CD ROM that
you mail to the mailing address
identified in Unit I.C.2. These electronic
submissions will be accepted in
WordPerfect or ASCII file format. Avoid
the use of special characters and any
form of encryption.
2. By mail. Send your comments to:
Public Information and Records
Integrity Branch (PIRIB) (7502C), Office
of Pesticide Programs (OPP),
Environmental Protection Agency, 1200
Pennsylvania Ave., NW., Washington,
DC 20460–0001, Attention: Docket ID
Number OPP–2005–0140.
3. By hand delivery or courier. Deliver
your comments to: Public Information
and Records Integrity Branch (PIRIB),
Office of Pesticide Programs (OPP),
Environmental Protection Agency, Rm.
119, Crystal Mall #2, 1801 S. Bell St.,
Arlington, VA, Attention: Docket ID
Number OPP–2005–0140. Such
deliveries are only accepted during the
docket’s normal hours of operation as
identified in Unit I.B.1.
D. How Should I Submit CBI to the
Agency?
Do not submit information that you
consider to be CBI electronically
through EPA’s electronic public docket
or by e-mail. You may claim
information that you submit to EPA as
CBI by marking any part or all of that
information as CBI (if you submit CBI
on disk or CD ROM, mark the outside
of the disk or CD ROM as CBI and then
identify electronically within the disk or
CD ROM the specific information that is
CBI). Information so marked will not be
disclosed except in accordance with
procedures set forth in 40 CFR part 2.
In addition to one complete version of
the comment that includes any
information claimed as CBI, a copy of
the comment that does not contain the
information claimed as CBI must be
submitted for inclusion in the public
docket and EPA’s electronic public
docket. If you submit the copy that does
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
36165
not contain CBI on disk or CD ROM,
mark the outside of the disk or CD ROM
clearly that it does not contain CBI.
Information not marked as CBI will be
included in the public docket and EPA’s
electronic public docket without prior
notice. If you have any questions about
CBI or the procedures for claiming CBI,
please consult the person listed under
FOR FURTHER INFORMATION CONTACT.
E. What Should I Consider as I Prepare
My Comments for EPA?
You may find the following
suggestions helpful for preparing your
comments:
1. Explain your views as clearly as
possible.
2. Describe any assumptions that you
used.
3. Provide copies of any technical
information and/or data you used that
support your views.
4. If you estimate potential burden or
costs, explain how you arrived at the
estimate that you provide.
5. Provide specific examples to
illustrate your concerns.
6. Make sure to submit your
comments by the deadline in this
notice.
7. To ensure proper receipt by EPA,
be sure to identify the docket ID number
assigned to this action in the subject
line on the first page of your response.
You may also provide the name, date,
and Federal Register citation.
II. What Action is the Agency Taking?
EPA has received a pesticide petition
as follows proposing the establishment
and/or amendment of regulations for
residues of a certain pesticide chemical
in or on various food commodities
under section 408 of the Federal Food,
Drug, and Cosmetic Act (FFDCA), 21
U.S.C. 346a. EPA has determined that
this petition contains data or
information regarding the elements set
forth in FFDCA section 408(d)(2);
however, EPA has not fully evaluated
the sufficiency of the submitted data at
this time or whether the data support
granting of the petition. Additional data
may be needed before EPA rules on the
petition.
List of Subjects
Environmental protection,
Agricultural commodities, Feed
additives, Food additives, Pesticides
and pests, Reporting and recordkeeping
requirements.
E:\FR\FM\22JNN1.SGM
22JNN1
36166
Federal Register / Vol. 70, No. 119 / Wednesday, June 22, 2005 / Notices
Dated: June 1, 2005.
Losi A. Rossi,
Director, Registration Division, Office of
Pesticide Programs.
Summary of Petition
The petitioner summary of the
pesticide petition is printed below as
required by FFDCA section 408(d)(3).
The summary of the petition was
prepared by the petitioner and
represents the view of the petitioner.
The petition summary announces the
availability of a description of the
analytical methods available to EPA for
the detection and measurement of the
pesticide chemical residues or an
explanation of why no such method is
needed.
Syngenta Crop Protection, Inc.
Pesticide Petition (PP) 6F4631
EPA has received PP 6F4631 from
Syngenta Crop Protection, Inc., P.O. Box
18300, Greensboro, NC, 27419–8300
proposing, pursuant to section 408(d) of
the FFDCA, 21 U.S.C. 346a(d), to amend
40 CFR 180.548 by establishing a
tolerance for residues of tralkoxydim, 2(Cyclohexen-1-one, 2-[1(ethoxyimino)propyl]-3-hydroxy- 5(2,4,6-trimethylphenyl)-(9Cl), in or on
the raw agricultural commodities barley
grain, barley hay, wheat grain, and
wheat hay at 0.02 parts per million
(ppm) and barley straw, wheat forage,
and wheat straw at 0.05 ppm. EPA has
determined that the petition contains
data or information regarding the
elements set forth in section 408(d)(2) of
the FFDCA; however, EPA has not fully
evaluated the sufficiency of the
submitted data at this time or whether
the data supports granting of the
petition. Additional data may be needed
before EPA rules on the petition.
A. Residue Chemistry
1. Plant metabolism. The nature of the
residue in barley, wheat, rotational
crops, and livestock is adequately
understood. The residues of concern for
the tolerance expression are parent per
se. Based on the results of animal
metabolism studies it is unlikely that
secondary residues would occur in
animal commodities from the use of
tralkoxydim on wheat and barley.
Tralkoxydim rapidly metabolizes in
plants, and no residues of parent are
detected at harvest. Extensive
metabolism in grain, forage and straw
occurs, with that none of the individual
metabolites exceeding 3.6% TRR.
2. Analytical method. An adequate
analytical method, gas chromatography/
mass spectrometry with selected ion
VerDate jul<14>2003
21:12 Jun 21, 2005
Jkt 205001
monitoring, is available for enforcement
purposes.
3. Magnitude of residues. Magnitude
of the residue trials conducted on spring
wheat, winter wheat, and barley showed
no detectable residues on wheat grain,
straw, hay, forage, or processed
commodities at the harvest timing
prescribed by the label. Based on the
results of animal metabolism studies it
is unlikely that significant residues
would occur in secondary animal
commodities from the use of
tralkoxydim on wheat and barley. The
nature of the residue in plants is
adequately understood.
B. Toxicological Profile
1. Acute toxicity. EPA has established
an acute Reference Dose (RfD) for
tralkoxydim of 0.3 milligrams/kilogram/
day (mg/kg/day). This RfD is based on
the no observed adverse effect level
(NOAEL) of 30 mg/kg/day established in
the rat developmental study and using
an uncertainty factor of 100 based on
10X for interspecies extrapolation and
10X for intraspecies variation.
2. Genotoxicty. Tralkoxydim was
negative for mutagenic/genotoxic effects
in a Gene mutation Ames Assay in
bacteria, a forward gene mutation in
mouse lymphoma cells in culture,
chromosome damage/In vitro assay in
human lymphocyte cells, DNA damage
repair in vivo assay in rat hepatocytes,
and chromosome damage in vivo mouse
micronuclei.
3.Reproductive and developmental
toxicity. The developmental and
reproductive toxicity data do not
indicate increase susceptibility of rats or
rabbits to in utero and/or postnatal
exposure to tralkoxydim. A 3–
generation rat reproduction study
indicated a parental systemic NOAEL of
200 ppm (20 mg/kg/day) and a systemic
lowest observed adverse effect level
(LOAEL) of 1,000 ppm (100 mg/kg/day)
based on reduced body weights and
body weight gains in females. No
reproductive toxicity was observed. A
rat developmental study with a maternal
NOAEL of 30 mg/kg/day and with a
maternal LOAEL of 200 mg/kg/day
based on maternal mortality, reduced
body weights, and reduced food
consumption and a developmental
NOAEL of 30 mg/kg/day and a
developmental LOAEL of 200 mg/kg/
day based on reduced ossification of the
centrum and hemicentrum, centrum
bipartite, misshapen centra and fused
centra. A rabbit developmental study
with a maternal NOAEL of 20 mg/kg/
day and a maternal LOAEL of 100 mg/
kg/day based on reduced food
consumption and a developmental
NOAEL of 20 mg/kg/day and a
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
developmental LOAEL of 100 mg/kg/
day based on abortions and increases in
late resorptions.
4. Subchronic toxicity.Tralkoxydim is
of low subchronic toxicity in 21–day
dermal testing.
5. Chronic toxicity. EPA has
established the RfD for tralkoxydim at
0.005 mg/kg/day. This RfD is based on
NOAEL of 0.5 mg/kg/day in the chronic
toxicity study in dogs with a 100–fold
uncertainty factor to account for
interspecies extrapolation (10x) and
intraspecies variability (10x). The
Health Effects Division Cancer
Assessment Review Committee has
classified Tralkoxydim in accordance
with the Agency’s Proposed Guidelines
for Carcinogen Risk Assessment (April
10, 1996) as a ‘‘likely to be human
carcinogen’’. This classification is based
on the following factors:
i. Occurrence of benign Leydig cell
tumors at all dose levels with the
incidences at the high dose exceeding
the concurrent and historical control
range.
ii. Lack of an acceptable
carcinogenicity study in a second
species as required by Subdivision F
Guidelines.
iii. The relevance of the testicular
tumors to human exposure can not be
discounted.
6. Animal metabolism. Based on the
results of animal metabolism studies it
is unlikely that significant residues
would occur in secondary animal
commodities from the use of
tralkoxydim on wheat and barley
7. Metabolite toxicology. The nature of
the residue in barley, wheat, rotational
crops, and livestock is adequately
understood. The residues of concern for
the tolerance expression are parent per
se.
8. Endocrine disruption. There has
been no evidence of endocrine
disruption concerns with resulting from
tralkoxydim use on wheat and barley.
C. Aggregate Exposure
1. Dietary exposure. The proposed
tolerances in or on the raw agricultural
commodities: Barley grain, barley hay,
wheat grain and wheat hay at 0.02 ppm,
and barley straw, wheat forage and
wheat straw at 0.05 ppm are the first to
be established for tralkoxydim. There is
no reasonable expectation of residues of
tralkoxydim occurring in meat, milk,
poultry, or eggs from its use on wheat
and barley. Risk assessments were
conducted by EPA to assess dietary
exposures from tralkoxydim as follows:
i. Acute exposure and risk. Acute
dietary risk assessments are performed
for a food-use pesticide if a toxicological
study has indicated the possibility of an
E:\FR\FM\22JNN1.SGM
22JNN1
Federal Register / Vol. 70, No. 119 / Wednesday, June 22, 2005 / Notices
effect of concern occurring as a result of
a one day or single exposure. An acute
dietary risk assessment was conducted
for tralkoxydim based on the NOAEL of
30 mg/kg/day from the rat
developmental study. The acute dietary
analysis using the Dietary Exposure
Evaluation Model (DEEMTM) computer
program estimates that the distribution
of single-day exposures utilizes 0.02%
of acute RfD.
ii. Chronic exposure and risk. The RfD
for Tralkoxydim is 0.005 mg/kg/day.
This value is based on the systemic
NOAEL of 0.5 mg/kg/day in the dog
chronic feeding study with a 100-fold
safety factor to account for interspecies
extrapolation (10x) and intraspecies
variability (10x).
2. Food. A DEEMTM chronic exposure
analysis was conducted using tolerance
levels for wheat and barley and
assuming that 100% of the crop is
treated to estimate dietary exposure for
the general population and 22
subgroups. The chronic analysis showed
that exposures from the tolerance level
residues in or on wheat, and barley for
children 1–6 years old (the subgroup
with the highest exposure) would be
1.4% of the RfD. The exposure for the
general U.S. population would be less
than 1% of the RfD.
iii. A lifetime dietary carcinogenicity
exposure analysis was conducted for
tralkoxydim using the proposed
tolerances along with the assumption of
100% of the crop treated and a Q* of
1.68 x 10-2 (mg/kg/day)-1. A lifetime risk
exposure analysis was also conducted
using the DEEMTM computer analysis.
The estimated cancer risk (5 x 10-7) is
less than the level that the Agency
usually considers for negligible cancer
risk estimates.
3. Drinking water. Drinking water
estimated concentrations (DWECs) for
surface water (parent tralkoxydim) were
calculated by EPA’s Pesticide Root Zone
Model (PRIZM) computer models to be
an average of 9.1 parts per billion (ppb).
The DWECs for ground water based on
the computer model screening
concentration in ground water (SCIGROW2) were calculated to be an
average of .016 ppb.
4. Non-dietary exposure. There are no
non-food uses of tralkoxydim currently
registered under the Federal Insecticide,
Fungicide and Rodenticide Act (FIFRA),
as amended. No non-dietary exposures
are expected for the general population.
D. Cumulative Effects
EPA does not have, at this time,
available data to determine whether
tralkoxydim has a common mechanism
of toxicity with other substances or how
to include this pesticide in a cumulative
VerDate jul<14>2003
21:12 Jun 21, 2005
Jkt 205001
risk assessment. Tralkoxydim is
structurally a cyclohexanedione. Unlike
other pesticides for which EPA has
followed a cumulative risk approach
based on a common mechanism of
toxicity, tralkoxydim does not appear to
produce a toxic metabolite produced by
other substances. For the purposes of
these tolerances action, therefore, EPA
has not assumed that tralkoxydim has a
common mechanism of toxicity with
other substances.
E. Safety Determination
1. U.S. population — i. Acute risk.
The acute dietary analysis based on the
NOAEL of 30 mg/kg/day from the rat
developmental study using the DEEMTM
computer program estimates that the
distribution of single-day exposures
utilizes 0.02% of acute RfD. The
drinking water level of comparisons
(DWLOCs) for acute exposure to
tralkoxydim in drinking water
calculated for females 13+ years old was
9,000 ppb. The estimated average
concentration in surface water for
tralkoxydim is 9 ppb. EPA’s acute
drinking water level of comparison is
well above the estimated exposures for
tralkoxydim in water for the subgroup of
concern. For ground water, the
estimated environmental concentrations
(EEC’s) using the SCI-GROW model
were all less than 1 ppb.
ii. Chronic risk. A DEEM chronic
exposure analysis showed that exposure
from tolerance level residues in or on
wheat, and barley for children 1–6 years
old (the subgroup with the highest
exposure) would be 1.4% of the RfD.
The exposure for the general U.S.
population would be less than 1% of the
RfD. The DWLOCs for chronic exposure
to tralkoxydim in drinking water
calculated for U.S. population was 150
ppb and for children (1–6 years old) the
DWLOC was 50 ppb. The estimated
average concentration in surface water
for tralkoxydim is 9 ppb. EPA’s chronic
drinking water level of concern is above
the estimated exposures for tralkoxydim
in water for the U.S. population and the
subgroup of concern. Conservative
model estimates (SCI-GROW) of the
concentrations of tralkoxydim in ground
water indicate that exposure will be
minimal.
iii. Cancer risk. A DWLOC for cancer
was calculated as 1 ppb. The estimated
concentration in surface water and
ground water for tralkoxydim for
chronic exposure are 0.9 ppb (2.8 ppb
(the 56–day concentration)/3) and 0.1
ppb, respectively. The model exposure
estimates are less than the cancer
DWLOC. EPA concludes that there is a
reasonable certainty that no harm will
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
36167
result from aggregate exposure to
tralkoxydim residues.
2. Infants and children. The Agency
concluded that an extra safety factor to
protect infants and children is not
needed based on the following
considerations: The toxicology data base
is complete for the assessment of special
sensitivity of infants and children; the
developmental and reproductive
toxicity data do not indicate increase
susceptibility of rats or rabbits to in
utero and/or postnatal exposure; the
NOAEL used in deriving the RfD is
based on changes in liver function and
morphology in male adult dogs (not
developmental or neurotoxic effects)
after chronic exposure and thus are not
relevant for enhanced sensitivity to
infants and children; unrefined dietary
exposure estimates (assuming all
commodities contain tolerance level
residues) overestimate dietary exposure;
model data used for ground and surface
source drinking water exposure
assessments result in estimates
considered to be upper-bound
concentrations; there are no registered
uses for tralkoxydim that could result in
residential exposures. EPA concludes
that there is a reasonable certainty that
no harm will result to children from
aggregate exposure to tralkoxydim
residues.
F. International Tolerances
There are no Codex Alimentarius
Commission (Codex) or Mexican
Maximum Residue Levels (MRLs) for
tralkoxydim at this time.
[FR Doc. 05–12076 Filed 6–21–05; 8:45 am]
BILLING CODE 6560–50–S
ENVIRONMENTAL PROTECTION
AGENCY
[FRL–7926–1]
Environmental Justice Strategic Plan
Framework and Outline
Environmental Protection
Agency (EPA).
ACTION: Public comment period.
AGENCY:
SUMMARY: The Office of Environmental
Justice seeks public comment on: (1)
The draft ‘‘Framework for Integrating
Environmental Justice’’; and (2)
‘‘Environmental Justice Strategic Plan
Outline,’’ which includes proposed
Environmental Justice Priorities (EJ
Priorities). These two draft documents
will be the foundation for the
Environmental Justice Strategic Plan for
2006–2011. EPA is drafting the
Environmental Justice Strategic Plan to
integrate its environmental justice
E:\FR\FM\22JNN1.SGM
22JNN1
Agencies
[Federal Register Volume 70, Number 119 (Wednesday, June 22, 2005)]
[Notices]
[Pages 36164-36167]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-12076]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[OPP-2005-0140; FRL-7715-6]
Tralkoxydim; Notice of Filing a Pesticide Petition to Establish a
Tolerance for a Certain Pesticide Chemical in or on Food
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the initial filing of a pesticide
petition proposing the establishment of regulations for residues of a
certain pesticide chemical in or on various food commodities.
DATES: Comments, identified by docket identification (ID) number OPP-
2005-0140, must be received on or before July 22, 2005.
ADDRESSES: Comments may be submitted electronically, by mail, or
through hand delivery/courier. Follow the detailed instructions as
provided in Unit I. of the SUPPLEMENTARY INFORMATION.
FOR FURTHER INFORMATION CONTACT: Jim Tompkins, Registration Division
(7505C), Office of Pesticide Programs, Environmental Protection Agency,
1200 Pennsylvania Ave., NW., Washington, DC 20460-0001; telephone
number: (703) 305-5697; e-mail address:Tompkins.Jim@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this Action Apply to Me?
You may be potentially affected by this action if you an
agricultural producer, food manufacturer, or pesticide manufacturer.
Potentially affected entities may include, but are not limited to:
Crop production (NAICS 111)
Animal production (NAICS 112)
Food manufacturing (NAICS 311)
Pesticide manufacturing (NAICS 32532)
This listing is not intended to be exhaustive, but rather provides
a guide for readers regarding entities likely to be affected by this
action. Other types of entities not listed in this unit could also be
affected. The North American Industrial Classification System (NAICS)
codes have been provided to assist you and others in determining
whether this action might apply to certain entities. If you have any
questions regarding the applicability of this action to a particular
entity, consult the person listed under FOR FURTHER INFORMATION
CONTACT.
B. How Can I Get Copies of this Document and Other Related Information?
1. Docket. EPA has established an official public docket for this
action under docket ID number OPP-2005-0140. The official public docket
consists of the documents specifically referenced in this action, any
public comments received, and other information related to this action.
Although a part of the official docket, the public docket does not
include Confidential Business Information (CBI) or other information
whose disclosure is restricted by statute. The official public docket
is the collection of materials that is available for public viewing at
the Public Information and Records Integrity Branch (PIRIB), Rm. 119,
Crystal Mall 2, 1801S. Bell St., Arlington, VA. This docket
facility is open from 8:30 a.m. to 4 p.m., Monday through Friday,
excluding legal holidays. The docket telephone number is (703) 305-
5805.
2. Electronic access. You may access this Federal Register document
electronically through the EPA Internet under the ``Federal Register''
listings at https://www.epa.gov/fedrgstr/.
An electronic version of the public docket is available through
EPA's electronic public docket and comment system, EPA Dockets. You may
use EPA Dockets at https://www.epa.gov/edocket/ to submit or view public
comments, access the index listing of the contents of the official
public docket, and to access those documents in the public docket that
are available electronically. Although not all docket materials may be
available electronically, you may still access any of the publicly
available docket materials through the docket facility identified in
Unit I.B.1. Once in the system, select ``search,'' then key in the
appropriate docket ID number.
Certain types of information will not be placed in the EPA Dockets.
Information claimed as CBI and other information whose disclosure is
restricted by statute, which is not included in the official public
docket, will not be available for public viewing in EPA's electronic
public docket. EPA's policy is that copyrighted material will not be
placed in EPA's electronic public docket but will be available only in
printed, paper form in the official public docket. To the extent
feasible, publicly available docket materials will be made available in
EPA's electronic public docket. When a document is selected from the
index list in EPA Dockets, the system will identify whether the
document is available for viewing in EPA's electronic public docket.
Although not all docket materials may be available electronically, you
may still access any of the publicly available docket materials through
the docket facility identified in Unit I.B. EPA intends to work towards
providing electronic access to all of the publicly available docket
materials through EPA's electronic public docket.
For public commenters, it is important to note that EPA's policy is
that public comments, whether submitted electronically or in paper,
will be made available for public viewing in EPA's electronic public
docket as EPA receives them and without change, unless the comment
contains copyrighted material, CBI, or other information whose
disclosure is restricted by statute. When EPA identifies a comment
containing copyrighted material, EPA will provide a reference to that
material in the version of the comment that is placed in EPA's
electronic public docket. The entire printed comment, including the
copyrighted material, will be available in the public docket.
Public comments submitted on computer disks that are mailed or
delivered to the docket will be transferred to EPA's electronic public
docket. Public comments that are mailed or delivered to the docket will
be scanned and placed in EPA's electronic
[[Page 36165]]
public docket. Where practical, physical objects will be photographed,
and the photograph will be placed in EPA's electronic public docket
along with a brief description written by the docket staff.
C. How and To Whom Do I Submit Comments?
You may submit comments electronically, by mail, or through hand
delivery/courier. To ensure proper receipt by EPA, identify the
appropriate docket ID number in the subject line on the first page of
your comment. Please ensure that your comments are submitted within the
specified comment period. Comments received after the close of the
comment period will be marked ``late.'' EPA is not required to consider
these late comments. If you wish to submit CBI or information that is
otherwise protected by statute, please follow the instructions in Unit
I.D. Do not use EPA Dockets or e-mail to submit CBI or information
protected by statute.
1. Electronically. If you submit an electronic comment as
prescribed in this unit, EPA recommends that you include your name,
mailing address, and an e-mail address or other contact information in
the body of your comment. Also include this contact information on the
outside of any disk or CD ROM you submit, and in any cover letter
accompanying the disk or CD ROM. This ensures that you can be
identified as the submitter of the comment and allows EPA to contact
you in case EPA cannot read your comment due to technical difficulties
or needs further information on the substance of your comment. EPA's
policy is that EPA will not edit your comment, and any identifying or
contact information provided in the body of a comment will be included
as part of the comment that is placed in the official public docket,
and made available in EPA's electronic public docket. If EPA cannot
read your comment due to technical difficulties and cannot contact you
for clarification, EPA may not be able to consider your comment.
i. EPA Dockets. Your use of EPA's electronic public docket to
submit comments to EPA electronically is EPA's preferred method for
receiving comments. Go directly to EPA Dockets at https://www.epa.gov/
edocket/, and follow the online instructions for submitting comments.
Once in the system, select ``search,'' and then key in docket ID number
OPP-2005-0140. The system is an ``anonymous access'' system, which
means EPA will not know your identity, e-mail address, or other contact
information unless you provide it in the body of your comment.
ii. E-mail. Comments may be sent by e-mail to opp-docket@epa.gov,
Attention: Docket ID Number OPP-2005-0140. In contrast to EPA's
electronic public docket, EPA's e-mail system is not an ``anonymous
access'' system. If you send an e-mail comment directly to the docket
without going through EPA's electronic public docket, EPA's e-mail
system automatically captures your e-mail address. E-mail addresses
that are automatically captured by EPA's e-mail system are included as
part of the comment that is placed in the official public docket, and
made available in EPA's electronic public docket.
iii. Disk or CD ROM. You may submit comments on a disk or CD ROM
that you mail to the mailing address identified in Unit I.C.2. These
electronic submissions will be accepted in WordPerfect or ASCII file
format. Avoid the use of special characters and any form of encryption.
2. By mail. Send your comments to: Public Information and Records
Integrity Branch (PIRIB) (7502C), Office of Pesticide Programs (OPP),
Environmental Protection Agency, 1200 Pennsylvania Ave., NW.,
Washington, DC 20460-0001, Attention: Docket ID Number OPP-2005-0140.
3. By hand delivery or courier. Deliver your comments to: Public
Information and Records Integrity Branch (PIRIB), Office of Pesticide
Programs (OPP), Environmental Protection Agency, Rm. 119, Crystal Mall
2, 1801 S. Bell St., Arlington, VA, Attention: Docket ID
Number OPP-2005-0140. Such deliveries are only accepted during the
docket's normal hours of operation as identified in Unit I.B.1.
D. How Should I Submit CBI to the Agency?
Do not submit information that you consider to be CBI
electronically through EPA's electronic public docket or by e-mail. You
may claim information that you submit to EPA as CBI by marking any part
or all of that information as CBI (if you submit CBI on disk or CD ROM,
mark the outside of the disk or CD ROM as CBI and then identify
electronically within the disk or CD ROM the specific information that
is CBI). Information so marked will not be disclosed except in
accordance with procedures set forth in 40 CFR part 2.
In addition to one complete version of the comment that includes
any information claimed as CBI, a copy of the comment that does not
contain the information claimed as CBI must be submitted for inclusion
in the public docket and EPA's electronic public docket. If you submit
the copy that does not contain CBI on disk or CD ROM, mark the outside
of the disk or CD ROM clearly that it does not contain CBI. Information
not marked as CBI will be included in the public docket and EPA's
electronic public docket without prior notice. If you have any
questions about CBI or the procedures for claiming CBI, please consult
the person listed under FOR FURTHER INFORMATION CONTACT.
E. What Should I Consider as I Prepare My Comments for EPA?
You may find the following suggestions helpful for preparing your
comments:
1. Explain your views as clearly as possible.
2. Describe any assumptions that you used.
3. Provide copies of any technical information and/or data you used
that support your views.
4. If you estimate potential burden or costs, explain how you
arrived at the estimate that you provide.
5. Provide specific examples to illustrate your concerns.
6. Make sure to submit your comments by the deadline in this
notice.
7. To ensure proper receipt by EPA, be sure to identify the docket
ID number assigned to this action in the subject line on the first page
of your response. You may also provide the name, date, and Federal
Register citation.
II. What Action is the Agency Taking?
EPA has received a pesticide petition as follows proposing the
establishment and/or amendment of regulations for residues of a certain
pesticide chemical in or on various food commodities under section 408
of the Federal Food, Drug, and Cosmetic Act (FFDCA), 21 U.S.C. 346a.
EPA has determined that this petition contains data or information
regarding the elements set forth in FFDCA section 408(d)(2); however,
EPA has not fully evaluated the sufficiency of the submitted data at
this time or whether the data support granting of the petition.
Additional data may be needed before EPA rules on the petition.
List of Subjects
Environmental protection, Agricultural commodities, Feed additives,
Food additives, Pesticides and pests, Reporting and recordkeeping
requirements.
[[Page 36166]]
Dated: June 1, 2005.
Losi A. Rossi,
Director, Registration Division, Office of Pesticide Programs.
Summary of Petition
The petitioner summary of the pesticide petition is printed below
as required by FFDCA section 408(d)(3). The summary of the petition was
prepared by the petitioner and represents the view of the petitioner.
The petition summary announces the availability of a description of the
analytical methods available to EPA for the detection and measurement
of the pesticide chemical residues or an explanation of why no such
method is needed.
Syngenta Crop Protection, Inc.
Pesticide Petition (PP) 6F4631
EPA has received PP 6F4631 from Syngenta Crop Protection, Inc.,
P.O. Box 18300, Greensboro, NC, 27419-8300 proposing, pursuant to
section 408(d) of the FFDCA, 21 U.S.C. 346a(d), to amend 40 CFR 180.548
by establishing a tolerance for residues of tralkoxydim, 2-(Cyclohexen-
1-one, 2-[1-(ethoxyimino)propyl]-3-hydroxy- 5-(2,4,6-trimethylphenyl)-
(9Cl), in or on the raw agricultural commodities barley grain, barley
hay, wheat grain, and wheat hay at 0.02 parts per million (ppm) and
barley straw, wheat forage, and wheat straw at 0.05 ppm. EPA has
determined that the petition contains data or information regarding the
elements set forth in section 408(d)(2) of the FFDCA; however, EPA has
not fully evaluated the sufficiency of the submitted data at this time
or whether the data supports granting of the petition. Additional data
may be needed before EPA rules on the petition.
A. Residue Chemistry
1. Plant metabolism. The nature of the residue in barley, wheat,
rotational crops, and livestock is adequately understood. The residues
of concern for the tolerance expression are parent per se. Based on the
results of animal metabolism studies it is unlikely that secondary
residues would occur in animal commodities from the use of tralkoxydim
on wheat and barley. Tralkoxydim rapidly metabolizes in plants, and no
residues of parent are detected at harvest. Extensive metabolism in
grain, forage and straw occurs, with that none of the individual
metabolites exceeding 3.6% TRR.
2. Analytical method. An adequate analytical method, gas
chromatography/mass spectrometry with selected ion monitoring, is
available for enforcement purposes.
3. Magnitude of residues. Magnitude of the residue trials conducted
on spring wheat, winter wheat, and barley showed no detectable residues
on wheat grain, straw, hay, forage, or processed commodities at the
harvest timing prescribed by the label. Based on the results of animal
metabolism studies it is unlikely that significant residues would occur
in secondary animal commodities from the use of tralkoxydim on wheat
and barley. The nature of the residue in plants is adequately
understood.
B. Toxicological Profile
1. Acute toxicity. EPA has established an acute Reference Dose
(RfD) for tralkoxydim of 0.3 milligrams/kilogram/day (mg/kg/day). This
RfD is based on the no observed adverse effect level (NOAEL) of 30 mg/
kg/day established in the rat developmental study and using an
uncertainty factor of 100 based on 10X for interspecies extrapolation
and 10X for intraspecies variation.
2. Genotoxicty. Tralkoxydim was negative for mutagenic/genotoxic
effects in a Gene mutation Ames Assay in bacteria, a forward gene
mutation in mouse lymphoma cells in culture, chromosome damage/In vitro
assay in human lymphocyte cells, DNA damage repair in vivo assay in rat
hepatocytes, and chromosome damage in vivo mouse micronuclei.
3.Reproductive and developmental toxicity. The developmental and
reproductive toxicity data do not indicate increase susceptibility of
rats or rabbits to in utero and/or postnatal exposure to tralkoxydim. A
3-generation rat reproduction study indicated a parental systemic NOAEL
of 200 ppm (20 mg/kg/day) and a systemic lowest observed adverse effect
level (LOAEL) of 1,000 ppm (100 mg/kg/day) based on reduced body
weights and body weight gains in females. No reproductive toxicity was
observed. A rat developmental study with a maternal NOAEL of 30 mg/kg/
day and with a maternal LOAEL of 200 mg/kg/day based on maternal
mortality, reduced body weights, and reduced food consumption and a
developmental NOAEL of 30 mg/kg/day and a developmental LOAEL of 200
mg/kg/day based on reduced ossification of the centrum and hemicentrum,
centrum bipartite, misshapen centra and fused centra. A rabbit
developmental study with a maternal NOAEL of 20 mg/kg/ day and a
maternal LOAEL of 100 mg/kg/day based on reduced food consumption and a
developmental NOAEL of 20 mg/kg/day and a developmental LOAEL of 100
mg/kg/day based on abortions and increases in late resorptions.
4. Subchronic toxicity.Tralkoxydim is of low subchronic toxicity in
21-day dermal testing.
5. Chronic toxicity. EPA has established the RfD for tralkoxydim at
0.005 mg/kg/day. This RfD is based on NOAEL of 0.5 mg/kg/day in the
chronic toxicity study in dogs with a 100-fold uncertainty factor to
account for interspecies extrapolation (10x) and intraspecies
variability (10x). The Health Effects Division Cancer Assessment Review
Committee has classified Tralkoxydim in accordance with the Agency's
Proposed Guidelines for Carcinogen Risk Assessment (April 10, 1996) as
a ``likely to be human carcinogen''. This classification is based on
the following factors:
i. Occurrence of benign Leydig cell tumors at all dose levels with
the incidences at the high dose exceeding the concurrent and historical
control range.
ii. Lack of an acceptable carcinogenicity study in a second species
as required by Subdivision F Guidelines.
iii. The relevance of the testicular tumors to human exposure can
not be discounted.
6. Animal metabolism. Based on the results of animal metabolism
studies it is unlikely that significant residues would occur in
secondary animal commodities from the use of tralkoxydim on wheat and
barley
7. Metabolite toxicology. The nature of the residue in barley,
wheat, rotational crops, and livestock is adequately understood. The
residues of concern for the tolerance expression are parent per se.
8. Endocrine disruption. There has been no evidence of endocrine
disruption concerns with resulting from tralkoxydim use on wheat and
barley.
C. Aggregate Exposure
1. Dietary exposure. The proposed tolerances in or on the raw
agricultural commodities: Barley grain, barley hay, wheat grain and
wheat hay at 0.02 ppm, and barley straw, wheat forage and wheat straw
at 0.05 ppm are the first to be established for tralkoxydim. There is
no reasonable expectation of residues of tralkoxydim occurring in meat,
milk, poultry, or eggs from its use on wheat and barley. Risk
assessments were conducted by EPA to assess dietary exposures from
tralkoxydim as follows:
i. Acute exposure and risk. Acute dietary risk assessments are
performed for a food-use pesticide if a toxicological study has
indicated the possibility of an
[[Page 36167]]
effect of concern occurring as a result of a one day or single
exposure. An acute dietary risk assessment was conducted for
tralkoxydim based on the NOAEL of 30 mg/kg/day from the rat
developmental study. The acute dietary analysis using the Dietary
Exposure Evaluation Model (DEEM\TM\) computer program estimates that
the distribution of single-day exposures utilizes 0.02% of acute RfD.
ii. Chronic exposure and risk. The RfD for Tralkoxydim is 0.005 mg/
kg/day. This value is based on the systemic NOAEL of 0.5 mg/kg/day in
the dog chronic feeding study with a 100-fold safety factor to account
for interspecies extrapolation (10x) and intraspecies variability
(10x).
2. Food. A DEEM\TM\ chronic exposure analysis was conducted using
tolerance levels for wheat and barley and assuming that 100% of the
crop is treated to estimate dietary exposure for the general population
and 22 subgroups. The chronic analysis showed that exposures from the
tolerance level residues in or on wheat, and barley for children 1-6
years old (the subgroup with the highest exposure) would be 1.4% of the
RfD. The exposure for the general U.S. population would be less than 1%
of the RfD.
iii. A lifetime dietary carcinogenicity exposure analysis was
conducted for tralkoxydim using the proposed tolerances along with the
assumption of 100% of the crop treated and a Q* of 1.68 x
10-\2\ (mg/kg/day)-\1\. A lifetime risk exposure
analysis was also conducted using the DEEM\TM\ computer analysis. The
estimated cancer risk (5 x 10-\7\) is less than the level
that the Agency usually considers for negligible cancer risk estimates.
3. Drinking water. Drinking water estimated concentrations (DWECs)
for surface water (parent tralkoxydim) were calculated by EPA's
Pesticide Root Zone Model (PRIZM) computer models to be an average of
9.1 parts per billion (ppb). The DWECs for ground water based on the
computer model screening concentration in ground water (SCI-GROW2) were
calculated to be an average of .016 ppb.
4. Non-dietary exposure. There are no non-food uses of tralkoxydim
currently registered under the Federal Insecticide, Fungicide and
Rodenticide Act (FIFRA), as amended. No non-dietary exposures are
expected for the general population.
D. Cumulative Effects
EPA does not have, at this time, available data to determine
whether tralkoxydim has a common mechanism of toxicity with other
substances or how to include this pesticide in a cumulative risk
assessment. Tralkoxydim is structurally a cyclohexanedione. Unlike
other pesticides for which EPA has followed a cumulative risk approach
based on a common mechanism of toxicity, tralkoxydim does not appear to
produce a toxic metabolite produced by other substances. For the
purposes of these tolerances action, therefore, EPA has not assumed
that tralkoxydim has a common mechanism of toxicity with other
substances.
E. Safety Determination
1. U.S. population -- i. Acute risk. The acute dietary analysis
based on the NOAEL of 30 mg/kg/day from the rat developmental study
using the DEEM\TM\ computer program estimates that the distribution of
single-day exposures utilizes 0.02% of acute RfD. The drinking water
level of comparisons (DWLOCs) for acute exposure to tralkoxydim in
drinking water calculated for females 13+ years old was 9,000 ppb. The
estimated average concentration in surface water for tralkoxydim is 9
ppb. EPA's acute drinking water level of comparison is well above the
estimated exposures for tralkoxydim in water for the subgroup of
concern. For ground water, the estimated environmental concentrations
(EEC's) using the SCI-GROW model were all less than 1 ppb.
ii. Chronic risk. A DEEM chronic exposure analysis showed that
exposure from tolerance level residues in or on wheat, and barley for
children 1-6 years old (the subgroup with the highest exposure) would
be 1.4% of the RfD. The exposure for the general U.S. population would
be less than 1% of the RfD. The DWLOCs for chronic exposure to
tralkoxydim in drinking water calculated for U.S. population was 150
ppb and for children (1-6 years old) the DWLOC was 50 ppb. The
estimated average concentration in surface water for tralkoxydim is 9
ppb. EPA's chronic drinking water level of concern is above the
estimated exposures for tralkoxydim in water for the U.S. population
and the subgroup of concern. Conservative model estimates (SCI-GROW) of
the concentrations of tralkoxydim in ground water indicate that
exposure will be minimal.
iii. Cancer risk. A DWLOC for cancer was calculated as 1 ppb. The
estimated concentration in surface water and ground water for
tralkoxydim for chronic exposure are 0.9 ppb (2.8 ppb (the 56-day
concentration)/3) and 0.1 ppb, respectively. The model exposure
estimates are less than the cancer DWLOC. EPA concludes that there is a
reasonable certainty that no harm will result from aggregate exposure
to tralkoxydim residues.
2. Infants and children. The Agency concluded that an extra safety
factor to protect infants and children is not needed based on the
following considerations: The toxicology data base is complete for the
assessment of special sensitivity of infants and children; the
developmental and reproductive toxicity data do not indicate increase
susceptibility of rats or rabbits to in utero and/or postnatal
exposure; the NOAEL used in deriving the RfD is based on changes in
liver function and morphology in male adult dogs (not developmental or
neurotoxic effects) after chronic exposure and thus are not relevant
for enhanced sensitivity to infants and children; unrefined dietary
exposure estimates (assuming all commodities contain tolerance level
residues) overestimate dietary exposure; model data used for ground and
surface source drinking water exposure assessments result in estimates
considered to be upper-bound concentrations; there are no registered
uses for tralkoxydim that could result in residential exposures. EPA
concludes that there is a reasonable certainty that no harm will result
to children from aggregate exposure to tralkoxydim residues.
F. International Tolerances
There are no Codex Alimentarius Commission (Codex) or Mexican
Maximum Residue Levels (MRLs) for tralkoxydim at this time.
[FR Doc. 05-12076 Filed 6-21-05; 8:45 am]
BILLING CODE 6560-50-S